MedTrace Logo

Safety and Performances of the LINEA Cardiac Pacing Lead Optimized for the Implantation in Interventricular Septum

NCT07342608 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 450

Last updated 2026-02-17

No results posted yet for this study

Summary

The purpose of the clinical investigation is to evaluate the safety and performances of the new LINEA cardiac pacing lead, intended for placement at the interventricular septum.

Conditions

  • Bradycardia
  • Left Bundle Branch Area Pacing
  • Left Bundle Branch Pacing

Interventions

DEVICE

Use of LINEA cardiac pacing lead

Use of LINEA cardiac pacing lead and delivery catheter for implantation of pacemaker

Sponsors & Collaborators

  • MicroPort CRM

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-31
Primary Completion
2027-01-31
Completion
2030-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07342608 on ClinicalTrials.gov